Eidos Therapeutics — San Francisco, California

Eidos Therapeutics is a clinical research site located in San Francisco, California, United States 94104.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Eidos Therapeutics has participated in 1 clinical trials.

Therapeutic areas: Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy.

Sponsors: Eidos Therapeutics, a BridgeBio company.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Eidos Therapeutics?

Eidos Therapeutics has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Eidos Therapeutics conducted?

Eidos Therapeutics has 1 clinical trials on record. Their work covers Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy.

Is Eidos Therapeutics accredited by Crixeo Health?

Eidos Therapeutics has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Eidos Therapeutics?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.